[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
|
[2] |
Singh N, Arif S. Histopathologic parameters of prognosis in cervical cancer - a review[J]. Int J Gynecol Cancer, 2004, 14(5): 741-750. DOI: 10.1111/j.1048-891X.2004.014504.x.
|
[3] |
Manetta A, Delgado G, Petrilli E, et al. The significance of paraaortic node status in carcinoma of the cervix and endometrium[J]. Gynecol Oncol, 1986, 23(3): 284-290. DOI: 10.1016/0090-8258(86)90128-9.
|
[4] |
Kumar S, Podratz KC, Bakkum-Gamez JN, et al. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer[J]. Gynecol Oncol, 2014, 132(1): 38-43. DOI: 10.1016/j.ygyno.2013.10.002.
|
[5] |
Castellino RA, Marglin SI. Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography?[J]. Invest Radiol, 1982, 17(5): 433-443. DOI: 10.1097/00004424-198209000-00001.
|
[6] |
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247. DOI: 10.1016/j.ejca.2008.10.026.
|
[7] |
Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1[J]. Eur J Cancer, 2009, 45(2): 261-267. DOI: 10.1016/j.ejca.2008.10.028.
|
[8] |
Benedetti Panici P, Basile S, Angioli R. Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact[J]. Gynecol Oncol, 2009, 113(2): 284-290. DOI: 10.1016/j.ygyno.2008.12.014.
|
[9] |
Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3. 2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(1): 64-84. DOI: 10.6004/jnccn.2019.0001
|
[10] |
ASTEC study group, Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study[J]. Lancet, 2009, 373(9658): 125-136. DOI: 10.1016/S0140-6736(08)61766-3.
|
[11] |
Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial[J]. J Natl Cancer Inst, 2008, 100(23): 1707-1716. DOI: 10.1093/jnci/djn397.
|
[12] |
|
[13] |
|
[14] |
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. NCCN guidelines insights: ovarian cancer, version 1. 2019[J]. J Natl Compr Canc Netw, 2019, 17(8): 896-909. DOI: 10.6004/jnccn.2019.0039.
|
[15] |
Ogino I, Okamoto N, Andoh K, et al. Analysis of prognostic factors in stageⅡ B - Ⅳ A cervical carcinoma treated with radiation therapy: value of computed tomography[J]. Int J Radiat Oncol Biol Phys, 1997, 37(5): 1071-1077. DOI: 10.1016/s0360-3016(96)00599-8.
|
[16] |
Yang WT, Lam WW, Yu MY, et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma[J]. AJR Am J Roentgenol, 2000, 175(3): 759-766. DOI: 10.2214/ajr.175.3.1750759.
|
[17] |
|
[18] |
Jung W, Park KR, Lee KJ, et al. Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer[J]. Radiat Oncol J, 2017, 35(4): 340-348. DOI: 10.3857/roj.2017.00206.
|